Overview

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

Status:
Active, not recruiting

Trial end date:
2023-06-30

Target enrollment:

Participant gender:

Summary

This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer to immunotherapy and to monitor any side effects.

Phase:

N/A

Details

Lead Sponsor:

West Virginia University

Collaborator:

West Virginia Clinical and Translational Science Institute

Treatments:

Immunologic Factors